{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:14:08Z","timestamp":1787616848417,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The use of anthracycline-based chemotherapy is associated with the development of heart failure, even years after the end of treatment. Early detection of cardiac dysfunction could identify a high-risk subset of survivors who would eventually benefit from early intervention. Cardiac magnetic resonance feature-tracking (CMR-FT) analysis offers a practical and rapid method to calculate systolic and diastolic strains from routinely acquired cine images. While early changes in systolic function have been described, less data are available about late effects of chemotherapy in diastolic parameters by CMR-FT. The main goal of this study was to determine whether left ventricular (LV) early diastolic strain rates (GDSR-E) by CMR-FT are impaired in long-term adult survivors of non-Hodgkin lymphoma (NHL). Our secondary objective was to analyze associations between GDSR-E with cumulative anthracycline dose, systolic function parameters and myocardial tissue characteristics.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a single center cross-sectional observational study of asymptomatic patients in remission of NHL who previously received anthracycline therapy. All participants underwent their CMR examination on a 3.0-T scanner, including cines, T2 mapping, T1 mapping and late gadolinium enhancement imaging. Derived myocardial extracellular volume fraction was obtained from pre- and post-contrast T1 maps. CMR-FT analysis was performed using Trufi Strain software. The data obtained\u00a0were compared between anthracycline group and volunteers without cardiovascular disease or neoplasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 18 adult survivors of NHL, 14 (77.8%) males, at mean age of 57.6 (\u00b1\u200914.7) years-old, were studied 88.2 (\u00b1\u200952.1) months after exposure to anthracycline therapy (median 400\u00a0mg\/m<jats:sup>2<\/jats:sup>). Compared with controls, anthracycline group showed impaired LV global early diastolic circumferential strain rate (GCSR-E) [53.5%\/s\u2009\u00b1\u200919.3 vs 72.2%\/s\u2009\u00b1\u200926.7, <jats:italic>p<\/jats:italic>\u2009=\u20090.022], early diastolic longitudinal strain rate (GLSR-E)\u00a0[40.4%\/s\u2009\u00b1\u200913.0 vs 55.9%\/s\u2009\u00b1\u200917.8, <jats:italic>p<\/jats:italic>\u2009=\u20090.006]\u00a0and early diastolic radial strain rate (GRSR-E) [\u2212\u2009114.4%\/s\u2009\u00b1\u200937.1 vs \u2212\u2009170.5%\/s\u2009\u00b1\u200948.0, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001]. Impaired LV GCSR-E, GLSR-E and GRSR-E correlated with increased anthracycline dose and decreased systolic function. There were no correlations between GDSR-E and myocardial tissue characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Left ventricular early diastolic strain rates by CMR-FT are impaired late after anthracycline chemotherapy in adult survivors of non-Hodgkin lymphoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-01996-6","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T11:04:43Z","timestamp":1618225483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-2275","authenticated-orcid":false,"given":"Maur\u00edcio Fregonesi","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-0150","authenticated-orcid":false,"given":"Dani\u00e9liso Renato","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-4995","authenticated-orcid":false,"given":"Rafael Dezen","family":"Gaiolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2334-2359","authenticated-orcid":false,"given":"Konrad","family":"Werys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2587-2759","authenticated-orcid":false,"given":"Suzana Erico","family":"Tanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1576-8090","authenticated-orcid":false,"given":"R\u00f4mulo Ara\u00fajo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-2814","authenticated-orcid":false,"given":"Sergio Marrone","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-7899","authenticated-orcid":false,"given":"Gilberto","family":"Szarf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"issue":"7","key":"1996_CR1","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-08-3392","volume":"107","author":"EC Moser","year":"2006","unstructured":"Moser EC, Noordijk EM, van Leeuwen FE, le Cessie S, Baars JW, Thomas J, et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood. 2006;107(7):2912\u20139.","journal-title":"Blood"},{"issue":"10","key":"1996_CR2","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","volume":"22","author":"O Hequet","year":"2004","unstructured":"Hequet O, Le QH, Moullet I, Pauli E, Salles G, Espinouse D, et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol. 2004;22(10):1864\u201371.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12253-008-9013-4","volume":"14","author":"AC Nagy","year":"2008","unstructured":"Nagy AC, Cserep Z, Tolnay E, Nagykalnai T, Forster T. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study. Pathol Oncol Res. 2008;14(1):69\u201377.","journal-title":"Pathol Oncol Res"},{"issue":"9","key":"1996_CR4","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","volume":"107","author":"H Sawaya","year":"2011","unstructured":"Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol. 2011;107(9):1375\u201380.","journal-title":"Am J Cardiol"},{"issue":"10","key":"1996_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","volume":"15","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M, et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15(10):1063\u201393.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"36","key":"1996_CR6","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Munoz D, Aboyans V, Asteggiano R, Galderisi M, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(36):2768\u2013801.","journal-title":"Eur Heart J"},{"issue":"8","key":"1996_CR7","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1200\/JCO.2007.14.8742","volume":"26","author":"MS Ewer","year":"2008","unstructured":"Ewer MS, Lenihan DJ. Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground? J Clin Oncol. 2008;26(8):1201\u20133.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1996_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale D, Colombo A, Lamantia G, Colombo N, Civelli M, De Giacomi G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55(3):213\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"1996_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, Tedeschi I, Meroni CA, Veglia F, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation. 2015;131(22):1981\u20138.","journal-title":"Circulation"},{"issue":"8","key":"1996_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","volume":"6","author":"BC Drafts","year":"2013","unstructured":"Drafts BC, Twomley KM, D\u2019Agostino R Jr, Lawrence J, Avis N, Ellis LR, et al. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imaging. 2013;6(8):877\u201385.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"1996_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.recesp.2016.12.021","volume":"70","author":"T Lopez-Fernandez","year":"2017","unstructured":"Lopez-Fernandez T, Martin Garcia A, Santaballa Beltran A, Montero Luis A, Garcia Sanz R, Mazon Ramos P, et al. Cardio-onco-hematology in clinical practice position paper and recommendations. Rev Esp Cardiol (Engl Ed). 2017;70(6):474\u201386.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"6","key":"1996_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/eurheartj\/ehi083","volume":"26","author":"R Hoffmann","year":"2005","unstructured":"Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, unenhanced and contrast-enhanced echocardiography. Eur Heart J. 2005;26(6):607\u201316.","journal-title":"Eur Heart J"},{"issue":"10","key":"1996_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","volume":"33","author":"M Ugander","year":"2012","unstructured":"Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33(10):1268\u201378.","journal-title":"Eur Heart J"},{"issue":"3","key":"1996_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/RTI.0000000000000077","volume":"29","author":"VM Ferreira","year":"2014","unstructured":"Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD. Myocardial tissue characterization by magnetic resonance imaging: novel applications of T1 and T2 mapping. J Thorac Imaging. 2014;29(3):147\u201354.","journal-title":"J Thorac Imaging"},{"issue":"1","key":"1996_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12968-017-0367-1","volume":"19","author":"K Yoneyama","year":"2017","unstructured":"Yoneyama K, Venkatesh BA, Bluemke DA, McClelland RL, Lima JAC. Cardiovascular magnetic resonance in an adult human population: serial observations from the multi-ethnic study of atherosclerosis. J Cardiovasc Magn Reson. 2017;19(1):52.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"1996_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/jmri.24623","volume":"41","author":"WE Moody","year":"2015","unstructured":"Moody WE, Taylor RJ, Edwards NC, Chue CD, Umar F, Taylor TJ, et al. Comparison of magnetic resonance feature tracking for systolic and diastolic strain and strain rate calculation with spatial modulation of magnetization imaging analysis. J Magn Reson Imaging. 2015;41(4):1000\u201312.","journal-title":"J Magn Reson Imaging"},{"issue":"10","key":"1996_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jcmg.2015.11.024","volume":"9","author":"HK Narayan","year":"2016","unstructured":"Narayan HK, French B, Khan AM, Plappert T, Hyman D, Bajulaiye A, et al. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction. JACC Cardiovasc Imaging. 2016;9(10):1131\u201341.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1996_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12968-017-0373-3","volume":"19","author":"MP Jolly","year":"2017","unstructured":"Jolly MP, Jordan JH, Melendez GC, McNeal GR, D\u2019Agostino RB Jr, Hundley WG. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy. J Cardiovasc Magn Reson. 2017;19(1):59.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1996_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijcard.2018.03.041","volume":"261","author":"G Ong","year":"2018","unstructured":"Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, Chow CM, et al. Myocardial strain imaging by cardiac magnetic resonance for detection of subclinical myocardial dysfunction in breast cancer patients receiving trastuzumab and chemotherapy. Int J Cardiol. 2018;261:228\u201333.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1996_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0735-1097(87)80099-2","volume":"9","author":"BH Lee","year":"1987","unstructured":"Lee BH, Goodenday LS, Muswick GJ, Yasnoff WA, Leighton RF, Skeel RT. Alterations in left ventricular diastolic function with doxorubicin therapy. J Am Coll Cardiol. 1987;9(1):184\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1996_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/0002-8703(89)90077-X","volume":"118","author":"B Marchandise","year":"1989","unstructured":"Marchandise B, Schroeder E, Bosly A, Doyen C, Weynants P, Kremer R, et al. Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J. 1989;118(1):92\u20138.","journal-title":"Am Heart J"},{"issue":"1","key":"1996_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0735-1097(92)90138-D","volume":"20","author":"MF Stoddard","year":"1992","unstructured":"Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992;20(1):62\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1996_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","volume":"7","author":"S Tassan-Mangina","year":"2006","unstructured":"Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C, et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr. 2006;7(2):141\u20136.","journal-title":"Eur J Echocardiogr"},{"issue":"1","key":"1996_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19(1):234.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1996_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1532-429X-11-56","volume":"11","author":"S Giri","year":"2009","unstructured":"Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009;11:56.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"6","key":"1996_CR26","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mrm.23153","volume":"67","author":"H Xue","year":"2012","unstructured":"Xue H, Shah S, Greiser A, Guetter C, Littmann A, Jolly MP, et al. Motion correction for myocardial T1 mapping using image registration with synthetic image estimation. Magn Reson Med. 2012;67(6):1644\u201355.","journal-title":"Magn Reson Med"},{"key":"1996_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1532-429X-14-63","volume":"14","author":"P Kellman","year":"2012","unstructured":"Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012;14:63.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"1996_CR28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1017\/S1047951113001182","volume":"24","author":"TJ Moon","year":"2014","unstructured":"Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF. Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy. Cardiol Young. 2014;24(5):854\u201365.","journal-title":"Cardiol Young"},{"issue":"12","key":"1996_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jcmg.2015.11.001","volume":"8","author":"P Claus","year":"2015","unstructured":"Claus P, Omar AMS, Pedrizzetti G, Sengupta PP, Nagel E. Tissue tracking technology for assessing cardiac mechanics. JACC Cardiovasc Imaging. 2015;8(12):1444\u201360.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"11","key":"1996_CR30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1161\/CIRCULATIONAHA.106.662882","volume":"115","author":"J Wang","year":"2007","unstructured":"Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF. Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation. 2007;115(11):1376\u201383.","journal-title":"Circulation"},{"issue":"10","key":"1996_CR31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.amjcard.2008.01.037","volume":"101","author":"H Dokainish","year":"2008","unstructured":"Dokainish H, Sengupta R, Pillai M, Bobek J, Lakkis N. Usefulness of new diastolic strain and strain rate indexes for the estimation of left ventricular filling pressure. Am J Cardiol. 2008;101(10):1504\u20139.","journal-title":"Am J Cardiol"},{"issue":"8","key":"1996_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1634\/theoncologist.2014-0500","volume":"20","author":"JM Serrano","year":"2015","unstructured":"Serrano JM, Gonzalez I, Del Castillo S, Muniz J, Morales LJ, Moreno F, et al. Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors. Oncologist. 2015;20(8):864\u201372.","journal-title":"Oncologist"},{"issue":"1","key":"1996_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/1096-911X(200007)35:1<13::AID-MPO3>3.0.CO;2-G","volume":"35","author":"LAJ Rammeloo","year":"2000","unstructured":"Rammeloo LAJ, Postma A, Sobotka-Plojhar MA, Bink-Boelkens MTE, Berg AD, Veerman AJP, et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. Med Pediatr Oncol. 2000;35(1):13\u20139.","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"1996_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfu057","volume":"140","author":"L Cove-Smith","year":"2014","unstructured":"Cove-Smith L, Woodhouse N, Hargreaves A, Kirk J, Smith S, Price SA, et al. An integrated characterisation of serological, pathological and functional events in doxorubicin-induced cardiotoxicity. Toxicol Sci. 2014;140(1):3\u201315.","journal-title":"Toxicol Sci"},{"issue":"1","key":"1996_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCHEARTFAILURE.114.001180","volume":"8","author":"M Moulin","year":"2015","unstructured":"Moulin M, Piquereau J, Mateo P, Fortin D, Rucker-Martin C, Gressette M, et al. Sexual dimorphism of doxorubicin-mediated cardiotoxicity: potential role of energy metabolism remodeling. Circ Heart Fail. 2015;8(1):98\u2013108.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"1996_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1067\/mje.2001.110375","volume":"14","author":"A Stoylen","year":"2001","unstructured":"Stoylen A, Slordahl S, Skjelvan GK, Heimdal A, Skjaerpe T. Strain rate imaging in normal and reduced diastolic function: comparison with pulsed Doppler tissue imaging of the mitral annulus. J Am Soc Echocardiogr. 2001;14(4):264\u201374.","journal-title":"J Am Soc Echocardiogr"},{"key":"1996_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/hc37t1.094834","volume":"104","author":"MS Firstenberg","year":"2001","unstructured":"Firstenberg MS, Smedira NG, Greenberg NL, Prior DL, McCarthy PM, Garcia MJ, et al. Relationship between early diastolic intraventricular pressure gradients, an index of elastic recoil, and improvements in systolic and diastolic function. Circulation. 2001;104:330\u20135.","journal-title":"Circulation"},{"key":"1996_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10554-018-1482-2","volume":"35","author":"IY Gong","year":"2019","unstructured":"Gong IY, Ong G, Brezden-Masley C, Dhir V, Deva DP, Chan KKW, et al. Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study. Int J Cardiovasc Imaging. 2019;35:653\u201362.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"1996_CR39","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s12350-015-0164-x","volume":"23","author":"EJ Reuvekamp","year":"2016","unstructured":"Reuvekamp EJ, Bulten BF, Nieuwenhuis AA, Meekes MR, de Haan AF, Tol J, et al. Does diastolic dysfunction precede systolic dysfunction in trastuzumab-induced cardiotoxicity? Assessment with multigated radionuclide angiography (MUGA). J Nucl Cardiol. 2016;23(4):824\u201332.","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"1996_CR40","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.64.5.827","volume":"64","author":"JC Gilbert","year":"1989","unstructured":"Gilbert JC, Glantz SA. Determinants of left ventricular filling and of the diastolic pressure-volume relation. Circ Res. 1989;64(5):827\u201352.","journal-title":"Circ Res"},{"issue":"7","key":"1996_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.106.638569","volume":"115","author":"R Martos","year":"2007","unstructured":"Martos R, Baugh J, Ledwidge M, O\u2019Loughlin C, Conlon C, Patle A, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation. 2007;115(7):888\u201395.","journal-title":"Circulation"},{"issue":"12","key":"1996_CR42","doi-asserted-by":"publisher","first-page":"e003584","DOI":"10.1161\/CIRCIMAGING.115.003584","volume":"9","author":"H Farhad","year":"2016","unstructured":"Farhad H, Staziaki PV, Addison D, Coelho-Filho OR, Shah RV, Mitchell RN, et al. Characterization of the changes in cardiac structure and function in mice treated with anthracyclines using serial cardiac magnetic resonance imaging. Circ Cardiovasc Imaging. 2016;9(12):e003584.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"1996_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2018.11.046","volume":"73","author":"C Galan-Arriola","year":"2019","unstructured":"Galan-Arriola C, Lobo M, Vilchez-Tschischke JP, Lopez GJ, de Molina-Iracheta A, Perez-Martinez C, et al. Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity. J Am Coll Cardiol. 2019;73(7):779\u201391.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1996_CR44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.amjcard.2012.11.022","volume":"111","author":"TG Neilan","year":"2013","unstructured":"Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, et al. Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Am J Cardiol. 2013;111(5):717\u201322.","journal-title":"Am J Cardiol"},{"issue":"275","key":"1996_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijcard.2018.10.023","volume":"15","author":"JD Haslbauer","year":"2019","unstructured":"Haslbauer JD, Lindner S, Valbuena-Lopez S, Zainal H, Zho H, D\u2019Angelo T, et al. CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping. Int J Cardiol. 2019;15(275):179\u201386.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1996_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ehjci\/jes139","volume":"14","author":"PW Stoodley","year":"2013","unstructured":"Stoodley PW, Richards DA, Boyd A, Hui R, Harnett PR, Meikle SR, et al. Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy. Eur Heart J Cardiovasc Imaging. 2013;14(3):228\u201334.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"1996_CR47","doi-asserted-by":"publisher","first-page":"e0175544","DOI":"10.1371\/journal.pone.0175544","volume":"12","author":"A Boyd","year":"2017","unstructured":"Boyd A, Stoodley P, Richards D, Hui R, Harnett P, Vo K, et al. Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLoS ONE. 2017;12(4):e0175544.","journal-title":"PLoS ONE"},{"issue":"19","key":"1996_CR48","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1161\/CIRCULATIONAHA.108.791681","volume":"119","author":"A Opdahl","year":"2009","unstructured":"Opdahl A, Remme EW, Helle-Valle T, Lyseggen E, Vartdal T, Pettersen E, et al. Determinants of left ventricular early-diastolic lengthening velocity: independent contributions from left ventricular relaxation, restoring forces, and lengthening load. Circulation. 2009;119(19):2578\u201386.","journal-title":"Circulation"},{"issue":"9","key":"1996_CR49","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jcmg.2015.07.004","volume":"8","author":"FA Flachskampf","year":"2015","unstructured":"Flachskampf FA, Biering-S\u00f8rensen T, Solomon SD, Duvernoy O, Bjerner T, Smiseth OA. Cardiac imaging to evaluate left ventricular diastolic function. JACC Cardiovasc Imaging. 2015;8(9):1071\u201393.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"1996_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12968-020-00636-w","volume":"22","author":"H Ito","year":"2020","unstructured":"Ito H, Ishida M, Makino W, Goto Y, Ichikawa Y, Kitagawa K, et al. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices. J Cardiovasc Magn Reson. 2020;22(1):42.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-01996-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T12:08:57Z","timestamp":1618229337000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-01996-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-01996-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"7 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was approved by the Research Ethics Committee of the Paulista Medical School\u2014UNIFESP (approval number: 897.237) and Botucatu Medical School\u2014UNESP (approval number: 969.316). Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"170"}}